Delivery Order SPE2DB22D3501-SPE2DB25FXE77
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dextrose 5%-Water intravenous solution in 100ML units, with a ceiling value of $1,152.47. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by December 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dextrose 5%-LR IV Solution in 1000ml containers, with a contract ceiling value of $2,184.84. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,600.80 to AmerisourceBergen Drug Corp for the supply of Dextrose 50%-Water Syringe 50mL on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the agency's procurement processes. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dextrose 50%-Water Syringe 50ML, with a ceiling value of $1,339.90. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency Troop Support Medical awarded a $124,350 delivery order to Amerisourcebergen Drug Corporation for 500ml bags of 5% dextrose in water intravenous solution. The contract has a firm fixed price and calls for delivery to Amerisourcebergen's facility in Conshohocken, Pennsylvania between August 25-28, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports procurement for medical supplies. This delivery order was issued...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded an $11,770 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to provide approximately 80 cases of 5% dextrose water intravenous solution. The contract has a period of performance from June 28, 2023 through July 26, 2023. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania. This delivery order was issued against the DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,169.20 to AmerisourceBergen Drug Corp for the supply of Dextrose 50%-Water Syringe 50ML on July 27, 2025. This contract utilizes firm fixed pricing with a completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, demonstrating the company's capability to meet federal medical supply requirements...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price of $1,605.20 for the supply of 250mL bags of 10% dextrose in water intravenous (IV) solution. The contract has a completion date of January 22, 2024 and was awarded on January 19, 2024. No set-aside designation was...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 50ml bags of 5% dextrose in water intravenous solution. The $1,199.19 order has a completion date of December 20, 2023. This delivery order was not set aside for any specific business type. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 50 mL dextrose 5% in water intravenous solution. The $2,236.53 award has a completion date of January 17, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts to supply pharmaceuticals, medical supplies, and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXE77Delivery Order
The Defense Logistics Agency awarded a $1,542.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500mL units of 70% dextrose-water intravenous solution. This delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, is a non-set-aside award issued under competitive procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's substantial IDC with DLA encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for dextrose solution reflects the company's ongoing role in supplying essential intravenous solutions and fluids required by the Defense Health Agency and other military healthcare systems under the broader pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/5/25 |